The Clinical Effects of Laser Acupuncture Therapy for OAB Women.

Overview

Overactive bladder (OAB) is a syndrome causes urgency, with or without urgent incontinence, daytime frequency and nocturia. Urgency incontinence is more common in older women and may be associated with comorbid conditions that occur with age. The standard OAB medical treatments may induced several intolerable side effects including dry mouth, constipation, and so on, therefore alternative therapies are often considered. Acupuncture had been proved effective to OAB treatment, however, this invasive procedure also cause pain and hematoma. Laser acupuncture has minimal side effects comparing to conventional acupuncture, but its effects against OAB had never been examined. Experiments with laser acupuncture are expected to be another way to relieve OAB symptoms.

Full Title of Study: “The Clinical Effects of Laser Acupuncture Therapy for OAB Women: a Randomized Controlled Trial.”

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: Randomized
    • Intervention Model: Parallel Assignment
    • Primary Purpose: Treatment
    • Masking: Double (Participant, Care Provider)
  • Study Primary Completion Date: April 5, 2022

Detailed Description

The subjects are treated with 7 acupoints which are localized according to WHO standardized acupressure point location guideline. The patients lay in the supine position before treatment and the gallium aluminum arsenide LaserPan (RJ-Laser, Reimers & Janssen GmbH, Waldkirch, Germany) will be applied to each selected acupoints mentioned above. The experimental group (verum laser acupuncture) and control group (sham laser acupuncture) will receive laser acupuncture 3 times per week for 3 weeks, total of 9 sessions, based on clinical experience (Treatment could be extended if necessary). The basic patient data will be recorded at baseline and adverse effect will also be recorded during the clinical trial.

Interventions

  • Device: Verum laser acupuncture
    • The patients lay in the supine position before treatment and the gallium aluminum arsenide LaserPan (RJ-Laser, Reimers & Janssen GmbH, Waldkirch, Germany) will be applied to each selected acupoints for 3 weeks, total of 9 sessions.
  • Device: Sham laser acupuncture
    • The acupuncture points and procedure of the control group are identical to the experimental group but there are no laser beam energy.

Arms, Groups and Cohorts

  • Experimental: Verum laser acupuncture
    • Verum laser acupuncture:Low level laser therapy stimulates 7 acupuncture points on both sides of the body .
  • Sham Comparator: Sham laser acupuncture
    • sham laser acupuncture (no laser output)

Clinical Trial Outcome Measures

Primary Measures

  • OAB symptom score (OABSS)
    • Time Frame: 3 weeks
    • This is a four symptoms questionnaire to quantify OAB symptoms.

Secondary Measures

  • The Urogenital Distress Inventory (UDI-6)
    • Time Frame: 3 weeks
    • This evaluation scale assesses symptom distress.

Participating in This Clinical Trial

Inclusion Criteria

1. Women are older than 18 years old. 2. Participant is willing to sign the consent. 3. Women havea moderate OAB symptoms. 4. Total scores of OABSS > 6 points and the 3rd question of OABSS > 2 points. 5. Not using anticholinergic drugs for more than three weeks. Exclusion Criteria:

1. Patients with lower urinary tract infection. 2. Patients who cannot complete the questionnaire. 3. Patients who use Botox to inject bladder and pelvic floor muscles within one year. 4. Pregnant patients. 5. Patients who continue to have electrical stimulation and acupuncture in the legs, waist and pelvis. 6. Patients with vaginal bleeding. 7. Other herbal and folklore therapies are being used to improve patients with overactive bladder.

Gender Eligibility: Female

Minimum Age: 20 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Chang Gung Memorial Hospital
  • Provider of Information About this Clinical Study
    • Sponsor
  • Overall Official(s)
    • Hsin-Ning Chang, Study Chair, Chang Gung Memorial Hospital
  • Overall Contact(s)
    • Hsin-Ning Chang, (02)24313131, 8705015@cgmh.org.tw

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.